Innate Pharma SA Current Provisions
Innate Pharma SA (IPHYF) had Current Provisions of EUR 3.48 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:CurrentProvisions · last filed 2026-04-01
- 2025-12-31: Current Provisions 3.48M EUR.
- 2025-06-30: Current Provisions 1.11M EUR.
- 2024-12-31: Current Provisions 207.00K EUR.
- 2024-06-30: Current Provisions 375.00K EUR.
| Period end | Current Provisions |
|---|---|
| 2025-12-31 | 3.48M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 1.11M EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 207.00K EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 375.00K EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 171.00K EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 1.75M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 1.54M EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 782.00K EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 647.00K EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 5.62M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 676.00K EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 114.00K EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 652.00K EUR 20-F · filed 2021-04-27 |